prostate cancer

https://www.pcf.org/c/beyond-the-prostate-dont-forget-about-the-rest-of-your-body/

Testosterone treatment for hypogonadal men with organ-confined prostate cancer and unequivocal hypogonadism is under scrutiny for its potential association with cancer recurrence. Physicians are cautious due to the testosterone dependence of metastatic prostate cancer. Previous studies lacked...

Men's Health Summit. Prostate Cancer is 100% treatable, but Black men disproportionately die from the condition. A panel of experts discusses how to break the stigma and myths about prostate cancer and Black men.

Convincing your PCP partners to screen for the early warning signs of prostate cancer does not have to be complicated. Learn how to develop an easy-to-follow risk stratification pathway to share with your PCP partners in this 12-minute talk from E. David Crawford, MD, Editor-in-Chief of Grand...

On this episode of BackTable Urology, Dr. Jose Silva invites endocrinologist Dr. Rodrigo Valderrabano onto the show to discuss the impact of testosterone replacement therapy on hypogonadic patients and prostate cancer survivors. First, Dr. Valderrabano explains the role of testosterone in the...

Transdermal square-wave testosterone therapy: A pilot trial in metastatic castration-resistant prostate cancer (2023) Nellowe Candelario, Andrew Nicklawsky, Laura Graham, Elaine T. Lam, Eryn Callihan, Michael Wacker, Thomas W. Flaig, Elizabeth R Kessler; the University of Colorado Cancer Center...

"We have become more advanced over time. We understand that men's health is more than just testosterone. Men's health is more than just erectile function and prostate disease," says Michael D. Lutz, MD...

Medical Oncologist Mark Scholz, MD gives a survey of testosterone replacement therapy (TRT) in the context of prostate cancer. Historically, some in the medical community have been hesitant to consider testosterone in patients with a history of prostate cancer out of fear of exacerbating the...

Phase III clinical trials have demonstrated the viability of intermittent hormone therapy in many patients with advanced prostate cancer -- this means that patients with undetectable PSAs who, in the past, would have been treated with hormone therapy for the rest of their lives can now consider...

How can we make prostate cancer screenings more helpful? Prof. Hendrik Van Poppel, MD, PhD has performed more than 2500 radical prostatectomies. For eight years, he had been the director of the European School of Urology (ESU), before becoming EAU Adjunct Secretary General, responsible for...

Discover the latest advancements in sexual rehabilitation for prostate cancer patients in this powerful panel discussion. Hear from top experts in the field, as they share their insights and offer practical tips for improving sexual function after prostate cancer treatment. Whether you're a...

Join us for a compassionate and insightful discussion about the impact of prostate cancer on sexual health and the available options for rehabilitation. This video offers a focus on evidence-based practices and real-world solutions. From the physical to the emotional, this panel covers the full...

Carolyn Salter, MD from Memorial Sloan Kettering Cancer Center, gives a patient-focused presentation about Androgen Deprivation Therapy, also known as "hormone therapy" for prostate cancer.

Urologist – Carolyn Salter, MD – Memorial Sloan Kettering Cancer Center *16:29-18:00 (testosterone therapy after prostate cancer) Prostate Cancer Patient Virtual Conference 2022 Presenters: Medical Oncologist – Karen Autio, MD – Memorial Sloan Kettering Cancer Center Epidemiologist –...